Wolff-Parkinson-White syndrome consensus statement: Difference between revisions
No edit summary |
|||
| Line 26: | Line 26: | ||
| 2a || Observation,without further evaluation or treatment,is reasonable in asymptomatic patients | | 2a || Observation,without further evaluation or treatment,is reasonable in asymptomatic patients | ||
with pre-excitation | with pre-excitation | ||
|} | |||
== Recommendations for Management of Symptomatic Patients With Manifest Accessory Pathways == | |||
{| class="wikitable" | |||
|- | |||
! Class of Recommendation !! Recommendations | |||
|- | |||
| 1 || In symptomatic patients with [[pre-excitation]], the findings of abrupt loss of conduction over the | |||
pathway during [[exercise testing]] in [[sinus rhythm]] or intermittent loss | |||
of [[pre-excitation]] during [[ECG]] or ambulatory monitoring are useful for | |||
identifying patients at lower risk of developing rapid conduction over the[[ pathway]] | |||
|- | |||
| 1 || An EP study is useful in symptomatic patients with [[pre-excitation]] to risk-stratify for | |||
life-threatening [[arrhythmic]] events | |||
|} | |} | ||
Revision as of 06:22, 15 September 2020
|
Wolff-Parkinson-White syndrome Microchapters |
|
Differentiating Wolff-Parkinson-White syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Wolff-Parkinson-White syndrome consensus statement On the Web |
|
Wolff-Parkinson-White syndrome consensus statement in the news |
|
Risk calculators and risk factors for Wolff-Parkinson-White syndrome consensus statement |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Sara Zand, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]; Kashish Goel, M.D.
Recommendations for Management of Asymptomatic Patients With Asymptomatic pre-excitation
- 2015 ACC-AHA Guideline[1]
| Class of Recommendation(COR) | Recommendations |
|---|---|
| 1 | In asymptomatic patients with pre-excitation, the findings of abrupt loss of conduction over
manifest pathway during exercise testing in sinus rhythm or intermittent loss of-excitation during ECG or ambulatory monitoring is useful to identify patients at low risk of rapid conduction over the pathway |
| 2a | An EP study is reasonable in asymptomatic patients with pre-excitation to risk-stratify for
arrhythmic events |
| 2a | Catheter ablation of the accessory pathway is reasonable in asymptomatic patients with pre-
excitation if an EP study identifies a high risk of arrhythmic events, including rapidly conducting pre-excited AF |
| 2a | Catheter ablation of the accessory pathway is reasonable in asymptomatic patients if the presence of
pre-excitation precludes specific employment(such as with pilots) |
| 2a | Observation,without further evaluation or treatment,is reasonable in asymptomatic patients
with pre-excitation |
Recommendations for Management of Symptomatic Patients With Manifest Accessory Pathways
| Class of Recommendation | Recommendations |
|---|---|
| 1 | In symptomatic patients with pre-excitation, the findings of abrupt loss of conduction over the
pathway during exercise testing in sinus rhythm or intermittent loss of pre-excitation during ECG or ambulatory monitoring are useful for identifying patients at lower risk of developing rapid conduction over thepathway |
| 1 | An EP study is useful in symptomatic patients with pre-excitation to risk-stratify for
life-threatening arrhythmic events |
References
- ↑ Page, Richard L.; Joglar, José A.; Caldwell, Mary A.; Calkins, Hugh; Conti, Jamie B.; Deal, Barbara J.; Estes III, N.A. Mark; Field, Michael E.; Goldberger, Zachary D.; Hammill, Stephen C.; Indik, Julia H.; Lindsay, Bruce D.; Olshansky, Brian; Russo, Andrea M.; Shen, Win-Kuang; Tracy, Cynthia M.; Al-Khatib, Sana M. (2016). "2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia". Heart Rhythm. 13 (4): e136–e221. doi:10.1016/j.hrthm.2015.09.019. ISSN 1547-5271.